Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
life sciences
national blog main
new york blog main
4
×
new york top stories
sanofi
4
×
national top stories
san francisco blog main
san francisco top stories
alirocumab
amgen
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
eli lilly
evolocumab
fda
inclisiran
indiana blog main
indiana top stories
national
pcsk9
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alector
alkermes
What
new
4
×
bio
cholesterol
deal
drug
known
medicines
wave
acquire
agreed
bets
billion
biopharma
brings
cancer
cash
comes
companies
company
compound
congress
congressional
crispr
cut
date
drugs
effective
enticed
evidence
executives
expensive
faces
fda
feud
financial
foe
group
hasn’t
healthcare
hint
Language
unset
Current search:
sanofi
×
" boston blog main "
×
new
×
" new york blog main "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines